"Designing Growth Strategies is in our DNA"

Influenza Vaccine Market Size, Share & COVID-19 Impact Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI101896

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Snapshot of Influenza Vaccine Rate – For Key Countries
    2. Annual Disease Burden of Influenza – For Key Countries/ Regions
    3. New Product Launches, By Key Players
    4. Influenza Vaccination Campaigns/Programs Undertaken by Government
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    6. Pricing Analysis – By Key Brand/Key Players, By Key Countries
    7. Overview: Recent Developments in Intradermal Patches
    8. Snapshot of Pipeline Analysis of Influenza Vaccines
    9. Overview: Adjuvant Influenza Vaccine, Pipeline Analysis, Projected Approvals, Market Size etc.
    10. Impact of COVID-19 on the Market
  5. Global Influenza Vaccine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Influenza Vaccine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S. – By Valency
      2. Canada – By Valency
  7. Europe Influenza Vaccine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K. – By Valency
      2. Germany – By Valency
      3. France – By Valency
      4. Italy – By Valency
      5. Spain – By Valency
      6. Scandinavia – By Valency
      7. Rest of Europe – By Valency
  8. Asia Pacific Influenza Vaccine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan – By Valency
      2. China – By Valency
      3. India – By Valency
      4. Australia – By Valency
      5. Korea – By Valency
      6. Rest of Asia Pacific – By Valency
  9. Latin America Influenza Vaccine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil – By Valency
      2. Mexico – By Valency
      3. Rest of Latin America – By Valency
  10. Middle East & Africa Influenza Vaccine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC Countries – By Valency
      2. South Africa – By Valency
      3. Rest of Middle East & Africa – By Valency
  11. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. AstraZeneca
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. CSL Limited (Seqirus)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. GlaxoSmithKline plc
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Sanofi
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. SINOVAC
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. BIKEN Co., Ltd.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Abbott
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Viatris Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Influenza Vaccine Market Revenue Breakdown (USD billion, %) by Region, 2021 & 2029

Figure 02: Global Influenza Vaccine Market Value Share (%), By Type, 2021 & 2029

Figure 03: Global Influenza Vaccine Market Value Share (%), By Valency, 2021 & 2029

Figure 04: Global Influenza Vaccine Market Value Share (%), By Age Group, 2021 & 2029

Figure 05: Global Influenza Vaccine Market Value Share (%), By Distribution Channel, 2021 & 2029

Figure 06: Global Influenza Vaccine Market Value Share (%), By Region, 2021 & 2029

Figure 07: North America Influenza Vaccine Market Value (USD billion), by Type, 2021 & 2029

Figure 08: North America Influenza Vaccine Market Value Share (%), by Type, 2021

Figure 09: North America Influenza Vaccine Market Value (USD billion), by Valency, 2021 & 2029

Figure 10: North America Influenza Vaccine Market Value Share (%), by Valency, 2021

Figure 11: North America Influenza Vaccine Market Value (USD billion), by Age Group, 2021 & 2029

Figure 12: North America Influenza Vaccine Market Value Share (%), by Age Group, 2021

Figure 13: North America Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 14: North America Influenza Vaccine Market Value Share (%), by Distribution Channel, 2021

Figure 15: North America Influenza Vaccine Market Value (USD billion), by Country, 2021 & 2029

Figure 16: North America Influenza Vaccine Market Value Share (%), by Country, 2021

Figure 17: Europe Influenza Vaccine Market Value (USD billion), by Type, 2021 & 2029

Figure 18: Europe Influenza Vaccine Market Value Share (%), by Type, 2021

Figure 19: Europe Influenza Vaccine Market Value (USD billion), by Valency, 2021 & 2029

Figure 20: Europe Influenza Vaccine Market Value Share (%), by Valency, 2021

Figure 21: Europe Influenza Vaccine Market Value (USD billion), by Age Group, 2021 & 2029

Figure 22: Europe Influenza Vaccine Market Value Share (%), by Age Group, 2021

Figure 23: Europe Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 24: Europe Influenza Vaccine Market Value Share (%), by Distribution Channel, 2021

Figure 25: Europe Influenza Vaccine Market Value (USD billion), by Country, 2021 & 2029

Figure 26: Europe Influenza Vaccine Market Value Share (%), by Country, 2021

Figure 27: Asia Pacific Influenza Vaccine Market Value (USD billion), by Type, 2021 & 2029

Figure 28: Asia Pacific Influenza Vaccine Market Value Share (%), by Type, 2021

Figure 29: Asia Pacific Influenza Vaccine Market Value (USD billion), by Valency, 2021 & 2029

Figure 30: Asia Pacific Influenza Vaccine Market Value Share (%), by Valency, 2021

Figure 31: Asia Pacific Influenza Vaccine Market Value (USD billion), by Age Group, 2021 & 2029

Figure 32: Asia Pacific Influenza Vaccine Market Value Share (%), by Age Group, 2021

Figure 33: Asia Pacific Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 34: Asia Pacific Influenza Vaccine Market Value Share (%), by Distribution Channel, 2021

Figure 35: Asia Pacific Influenza Vaccine Market Value (USD billion), by Country, 2021 & 2029

Figure 36: Asia Pacific Influenza Vaccine Market Value Share (%), by Country, 2021

Figure 37: Latin America Influenza Vaccine Market Value (USD billion), by Type, 2021 & 2029

Figure 38: Latin America Influenza Vaccine Market Value Share (%), by Type, 2021

Figure 39: Latin America Influenza Vaccine Market Value (USD billion), by Valency, 2021 & 2029

Figure 40: Latin America Influenza Vaccine Market Value Share (%), by Valency, 2021

Figure 41: Latin America Influenza Vaccine Market Value (USD billion), by Age Group, 2021 & 2029

Figure 42: Latin America Influenza Vaccine Market Value Share (%), by Age Group, 2021

Figure 43: Latin America Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 44: Latin America Influenza Vaccine Market Value Share (%), by Distribution Channel, 2021

Figure 45: Latin America Influenza Vaccine Market Value (USD billion), by Country, 2021 & 2029

Figure 46: Latin America Influenza Vaccine Market Value Share (%), by Country, 2021

Figure 47: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Type, 2021 & 2029

Figure 48: Middle East & Africa Influenza Vaccine Market Value Share (%), by Type, 2021

Figure 49: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Valency, 2021 & 2029

Figure 50: Middle East & Africa Influenza Vaccine Market Value Share (%), by Valency, 2021

Figure 51: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Age Group, 2021 & 2029

Figure 52: Middle East & Africa Influenza Vaccine Market Value Share (%), by Age Group, 2021

Figure 53: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 54: Middle East & Africa Influenza Vaccine Market Value Share (%), by Distribution Channel, 2021

Figure 55: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Country, 2021 & 2029

Figure 56: Middle East & Africa Influenza Vaccine Market Value Share (%), by Country, 2021

Figure 57: Global Influenza Vaccine Market Share (%), 2021

Table 01: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 02: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 03: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2018–2029

Table 04: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 05: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Region, 2018–2029

Table 06: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 07: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 08: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2018–2029

Table 09: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 10: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 11: U.S. Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 12: Canada Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 13: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 14: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 15: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2018–2029

Table 16: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 17: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 18: Germany Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 19: U.K. Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 20: France Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 21: Italy Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 22: Spain Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 23: Scandinavia Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 24: Rest of Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 25: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 26: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 27: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2018–2029

Table 28: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 29: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 30: Japan Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 31: Korea Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 32: China Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 33: India Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 34: Australia Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 35: Rest of Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 36: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 37: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 38: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2018–2029

Table 39: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 40: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 41: Brazil Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 42: Mexico Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 43: Rest of Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 44: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 45: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 46: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2018–2029

Table 47: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 48: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 49: GCC Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 50: South Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

Table 51: Rest of Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2018–2029

  • Sep, 2022
  • 2021
  • 2018-2020
  • 172

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X